Jessica Rouge, Ph.D.

Assistant Professor of Chemistry University of Connecticut

  • Storrs CT

Professor Rouge is an expert in enzyme-mediated assembly of nanomaterials and delivery of DNA and RNA into cells.

Contact

University of Connecticut

View more experts managed by University of Connecticut

Biography

Professor Rouge researches nanoparticles for drug delivery. She seeks to understand how enzymes and nucleic acids can be used in new ways to engineer highly specific and targeted responses in chemical and biological systems. Developing new chemical strategies for assembling catalytic RNA sequences at nanoparticle surfaces has sensing, diagnostic and therapeutic applications.

Areas of Expertise

SELEX
Therapeutic Oligonucleotides
Gene Regulation
Nanocharacterization

Education

Northwestern University

Postdoctoral Fellow

Chemistry

2015

University of Colorado

Ph.D.

Chemistry

2012

Boston College

B.S.

Biochemistry

2006

Accomplishments

NFS Career Award

NSF CAREER Award (2019)

Social

Media

Media Appearances

New Drug Delivery System Targets Diseases at a Genetic Level

Technology Networks  online

2017-12-06

"There's no one-size-fits-all delivery system," says Jessica Rouge, assistant professor of chemistry at UConn, and author of a new paper on the technology in Bioconjugate Chemistry. "The beauty of this system is that it is programmable, modular, and has the ability to rapidly integrate diverse peptide sequences. It can be tailored to combat new disease challenges as they emerge."

The delivery platform, featured in the paper by Rouge and her research team, combines synthetic peptides, surfactants, and nucleic acids to form a nanocapsule that allows time-appropriate, enzyme-specific co-release of a given pharmaceutical and an oligonucleotide (DNA or RNA).

These findings build on Rouge's work to understand how enzymes and nucleic acids can be used in new ways to engineer highly specific and targeted responses in chemical and biological systems.

View More

Patents

Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

US20180369158A1

The present disclosure provides multifunctional nanoparticles. More particularly, the present disclosure relates to multifunctional nanoparticles having one or more of nucleic acid ligands; and methods of using such nanoparticles for treatment and/or diagnosis of diseases and conditions.

View more

Universal enzyme responsive linker for assembling ligands on dna functionalized nanomaterials

US20180258114A1

Described herein is an enzyme-mediated approach to bioconjugation at nanoparticle (NP) surfaces. This process is enabled by a new synthetic linker compatible with the covalent attachment of alkyne modified substrates, including dyes, peptides and nucleic acids. The methods described herein specifically allow for the linkage of molecules to a DNA-functionalized nanoparticle surface.

View more

Duplex-selective organometallic DNA intercalators

US9969759B2

Disclosed herein are organometallic complexes and methods of using the same in detecting double stranded DNA or RNA, selectively over single stranded DNA or RNA.

View more

Articles

Controlled release of small molecules and proteins from DNA-surfactant stabilized metal organic frameworks

Journal of Materials Chemistry

2020

This work highlights a multifunctional nanoscale material which can effectively compartmentalize small molecules and biomolecules into a single, micellar structure with programmable degradation properties resulting in highly controllable release properties. The nanomaterial consists of a ZIF-8 metal organic framework (MOF) encapsulated within a DNA surfactant micelle assembly, referred to as a nucleic acid nanocapsule (NAN).

View more

Chimeric siRNA-DNA Surfactants for the Enhanced Delivery and Sustained Cytotoxicity of a Gold(III) Metallodrug

ACS Publications

2020

The optimized delivery and distribution of the compound is monitored by both fluorescence microscopy and inductively coupled plasma mass spectrometry. We show that codelivery of the AP228 and Bcl-2 targeting siRNA results in a substantial increase in drug efficacy, wherein the cytotoxic therapeutic effects of the drug are maximized, reducing the IC50 from 760 nM to 11 nM.

View more

Enzymatically Ligated DNA–Surfactants: Unmasking Hydrophobically Modified DNA for Intracellular Gene Regulation

Chembiochem

2018

Herein, we describe the characterization of a novel self‐assembling and intracellular disassembling nanomaterial for nucleic acid delivery and targeted gene knockdown. By using a recently developed nucleic acid nanocapsule (NAN) formed from surfactants and conjugated DNAzyme (DNz) ligands, it is shown that DNz–NAN can enable cellular uptake of the DNAzyme and result in 60 % knockdown of a target gene without the use of transfection agents.

View more

Show All +